Advertisement

InFo Neurologie & Psychiatrie

, Volume 21, Issue 1, pp 26–32 | Cite as

Hirnnervenneuropathie

Differenzialdiagnose und Therapie der peripheren Fazialisparese

  • Oliver KastrupEmail author
  • Jana Becker
zertifizierte fortbildung
  • 204 Downloads

Zusammenfassung

Die periphere Fazialisparese ist die häufigste Hirnnervenneuropathie. Diese Lähmung des N. facialis ist entweder idiopathisch oder es können spezifische Ursachen identifiziert werden. Nach dem heutigen Kenntnisstand handelt es sich in den meisten Fällen um eine Virusreaktivierung. Die Behandlung erfolgt im Akutstadium mit Steroiden und gegebenenfalls mit Aciclovir, die Prognose ist üblicherweise gut.

Literatur

  1. 1.
    Kennedy PG. Herpes simplex virus type 1 and Bell’s palsy-a current assessment of the controversy. J Neurovirol 2010;16:1–5CrossRefGoogle Scholar
  2. 2.
    Theil D, Arbusow V, Defuss T, Strupp M, Pfeiffer M, Mascolo A, Brandt T. Prevelance of HSV-1 LAT in human trigeminal, geniculate and vestibular ganglia and its implication for cranial nerve syndromes. Brain Pathology 2001;11:408–413CrossRefGoogle Scholar
  3. 3.
    Murakami S, Mizobuchi M, Nakashiro Y, Takashi D, Hato N, Yanagihara N. Bell’s palsy and herpes simplex virus: identification of viral DAN in endoneurial fluid and muscle. Ann Intern Med 1996;124:27–30CrossRefGoogle Scholar
  4. 4.
    House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg 1985;93(2):146–7CrossRefGoogle Scholar
  5. 5.
    Dumitru D, Walsh NE, Porter LD. Electrophysiologic evaluation of the facial nerve in Bell’s palsy. A review. Am J Phys Med Rehabil 1988;67:137–144CrossRefGoogle Scholar
  6. 6.
    Nowak DA, Linder S, Topka H. Diagnostic relevance of transcranial magnetic and electric stimulation of the facial nerve in the management of facial palsy. Clin Neurophysiol 2005;116:2051–7CrossRefGoogle Scholar
  7. 7.
    May M, Blumenthal F, Klein SR. Acute Bell’s palsy: prognostic value of evoked electromyography, maximal stimulation, and other electrical tests. Am J Otol 1983;5:1–7PubMedGoogle Scholar
  8. 8.
    Jonsson L, Tien R, Engstrom M, Thuomas K. GD-DPTA enhanced MRI in Bell’s palsy and herpes zoster oticus: an overview and implications for future studies. Acta Otolaryngol (Stockh.) 1995;115Google Scholar
  9. 9.
    Birkmann C, Bamborschke S, Halber M, Haupt WF. Bell’s palsy: electrodiagnostics are not indicative of cerebrospinal fluid abnormalities. Ann Otol Rhinol Laryngol 2001;110:581–4CrossRefGoogle Scholar
  10. 10.
    Rowlands S, Hooper R, Hughes R, Burney P The epidemilogy and treatment of Bell’s palsy in the UK. Eur J of Neurol 2002;9:63–7CrossRefGoogle Scholar
  11. 11.
    Salinas RA, Alvarez G, Daly F, Ferreira J. Corticosteroids for Bell’s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2010;3:CD001942Google Scholar
  12. 12.
    Jabor MA, Gianoli G. Management of Bell’s palsy. J La State Med Soc 1996;148(7):279–83Google Scholar
  13. 13.
    Gillman GS, Schaitkin BM, May M, Klein SR. Bell’s palsy in pregnancy: a study of recovery outcomes. Otolaryngol Head Neck Surg 2002;126:26–30CrossRefGoogle Scholar
  14. 14.
    Kanazawa A, Haginomori S, Takamaki A, Nonaka R, Araki M, Takenaka H. Prognosis for Bell’s palsy: a comparison of diabetic and nondiabetic patients. Acta Otolaryngol 2007;127:888–91CrossRefGoogle Scholar
  15. 15.
    Peitersen E. Bell’s palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 2002;4–30Google Scholar
  16. 16.
    Quant EC, Jeste SS, Muni RH, Cape AV, Bhussar MK, Peleg AY. The benefits of steroids versus steroids plus antivirals for treatment of Bell’s palsy: a meta-analysis. BMJ 2009;339:3354CrossRefGoogle Scholar
  17. 17.
    Lockhart P, Daly F, Pitkethly M, Comerford N, Sullivan F. Antiviral treatment for Bell’s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2009;7:CD001869Google Scholar
  18. 18.
    Uscategui T, Doree C, Chamberlain IJ, Burton MJ. Corticosteroids as adjuvant to antiviral treatment in Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults. Cochrane Database Syst Rev 2008a;16:CD006852Google Scholar
  19. 19.
    Adour KK, Ruboyianes JM, von Doersten PG, Byl FM, Trent CS, Quesenberry CP, Hitchcock T. Bell’s palsy treatment with acyclovir and prednisone alone: a double blind, randomized, controlled trial. Ann Otol Rhinol Laryngol 1996;105:371–8CrossRefGoogle Scholar
  20. 20.
    Almeida de JR, Al Khabori M, Guyatt GH, Witterick IJ, Lin VY, Nedzelski JM, Chen JM. Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis. JAMA 2009;302:985–93CrossRefGoogle Scholar
  21. 21.
    Grogan PM, Gronseth GS. Practice parameter: steroids, acyclovir, and surgery for Bell’s palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:830–6CrossRefGoogle Scholar
  22. 22.
    Engström M, Berg T, Stjernquist-Desatnik A, Axelsson S, Pitkäranta A, Hultcrantz M, Kanerva M, Hanner P, Jonsson L. Prednisolone and valaciclovir in Bell’s palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol 2008;7:993–1000CrossRefGoogle Scholar
  23. 23.
    Hato N, Yamada H, Kohno H, Matsumoto S, Honda N, Gyo K, Fukuda S, Furuta Y, Ohtani F, Aizawa H, Aoyagi M, Inamura H, Nakashima T, Nakata S, Murakami S, iKiguchi J, Yamano K, Takeda T, Hamada M, Yamakawa K. Valaciclovir and prednisolone treatment for Bell’s palsy: a multicenter, randomized, placebo-controlled study. Otol Neurotol 2007;28:408–13CrossRefGoogle Scholar
  24. 24.
    Catalano PJ, Bergstein MJ, Biller HF Comprehensive management of the eye in facial paralysis. Arch Otolaryngol Head Neck Surg 1995;121:81–6CrossRefGoogle Scholar
  25. 25.
    Teixeira LJ, Soares BG, Vieira VP, Prado GF. Physical therapy for Bell’s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2008;3:CD006283Google Scholar
  26. 26.
    Bulstrode NW, Harrison DH. The phenomenon of the late recovered Bell’s palsy: treatment options to improve facial symmetry. Plast Reconstr Surg 2005;115:1466–71CrossRefGoogle Scholar
  27. 27.
    Swan I, Donnan P, McAllister K, Walker D. Surgical interventions for the early management of Bell’s palsy. Cochrane Database of Syst Rev 2008;4:CD007468.Google Scholar
  28. 28.
    Lee EI, Hurvitz KA, Evans GR, Wirth GA. Cross-facial nerve graft: past and present. J Plast Reconstr Aesthet Surg 2008;61:250–6CrossRefGoogle Scholar
  29. 29.
    Chen N, Zhou M, He L, Zhou D, Li N. Acupuncture for Bell’s palsy. Cochrane Database Syst Rev 2010;8:CD002914Google Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Klinik für Neurologie und klinische Neurophysiologie, PhilippusstiftEssenDeutschland

Personalised recommendations